Last checked at 23 Jul 2020 16:03
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hutchmed Share News (HCM)
HCM Share
Price
HCM Share
News
HCM Share
Chat
HCM Share
Trades53
HCM
Live RNS
HCM Share
Charts
HCM Level 2
Console
HCM Live
Share Price
HCM Broker
Ratings
HCM Directors
Deals
HCM Financial
Diary
HCM
Fundamentals
HCM Short
Positions
HCM
Media
Hutchmed Information
Share Price Information for Hutchmed (HCM)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
300.00
Bid:
299.00
Ask:
300.00
Change:
2.50 (0.84%)
Spread:
1.00 (0.334%)
Open:
292.00
High:
303.00
Low:
292.00
Prev. Close:
297.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.23 Jul 2020 16:02
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more25 Jun 2020 15:08
Hutchison China Gets USD100 Million From US Private Equity Firm
Hutchison China Gets USD100 Million From US Private Equity Firm
Read more18 Jun 2020 16:46
IN BRIEF: Hutchison China Gets US FDA Fast Track For Cancer Drug
IN BRIEF: Hutchison China Gets US FDA Fast Track For Cancer Drug
Read more18 Jun 2020 09:18
Hutchison Chi-Med gets FDA fast track approval for fruquintinib
(Sharecast News) - Hutchison China MediTech, trading as 'Chi-Med', announced on Thursday that the US Food and Drug Administration (FDA) has granted 'fast track designation' for the development of 'fruquintinib'.
Read more9 Jun 2020 14:06
Hutchison Chi-Med venture to surrender unused land in Guangzhou
(Sharecast News) - Hutchison China MediTech, trading as 'Chi-Med', announced on Tuesday that Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company (HBYS) - its 50-50 joint venture with Guangzhou Baiyunshan Pharmaceutical Holdings - has agreed the planned return of its remaining 34 years land-use rights on its 30,000 square metre unused site in Tong He Town with the Guangzhou government.
Read more9 Jun 2020 13:25
UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser
UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser
Read more4 Jun 2020 13:19
UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service
UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service
Read more1 Jun 2020 15:54
UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks
UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks
Read more29 May 2020 17:06
UK TRADING UPDATE SUMMARY: New Trend Lifestyle Sees Extended Turmoil
UK TRADING UPDATE SUMMARY: New Trend Lifestyle Sees Extended Turmoil
Read more17 Apr 2020 13:19
Hutchison China Gets US FDA Fast Track Status For Surufatinib
Hutchison China Gets US FDA Fast Track Status For Surufatinib
Read more3 Mar 2020 14:24
Hutchison China Sees Loss Widen But Lays "Foundations" In 2019
Hutchison China Sees Loss Widen But Lays "Foundations" In 2019
Read more25 Feb 2020 16:05
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more12 Feb 2020 17:27
FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials
By Tamara Mathias, Roxanne Liu and Manojna MaddipatlaFeb 12 (Reuters) - The fast-spreading coronavirus is starting to disrupt testing of experimental medicines in China, posing a threat to plans by global drugmakers that have invested billions of ...
Read more10 Feb 2020 07:36
Hutchison Chi-Med shares up on updated results from 'CALYPSO'
(Sharecast News) - Hutchison China MediTech, trading as Chi-Med, announced the availability of updated results from the phase 2 'CALYPSO' study of the savolitinib and 'Imfinzi' (durvalumab) combination in a cohort of patients with metastatic papillary renal cell carcinoma (PRCC) on Monday.
Read more